These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 15356076

  • 21. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients.
    Miyazaki Y, Mahankali A, Matsuda M, Mahankali S, Hardies J, Cusi K, Mandarino LJ, DeFronzo RA.
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2784-91. PubMed ID: 12050251
    [Abstract] [Full Text] [Related]

  • 22. Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes.
    Kashyap SR, Belfort R, Berria R, Suraamornkul S, Pratipranawatr T, Finlayson J, Barrentine A, Bajaj M, Mandarino L, DeFronzo R, Cusi K.
    Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E537-46. PubMed ID: 15126243
    [Abstract] [Full Text] [Related]

  • 23. Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients.
    Miyazaki Y, Glass L, Triplitt C, Matsuda M, Cusi K, Mahankali A, Mahankali S, Mandarino LJ, DeFronzo RA.
    Diabetologia; 2001 Dec; 44(12):2210-9. PubMed ID: 11793023
    [Abstract] [Full Text] [Related]

  • 24. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects.
    Santomauro AT, Boden G, Silva ME, Rocha DM, Santos RF, Ursich MJ, Strassmann PG, Wajchenberg BL.
    Diabetes; 1999 Sep; 48(9):1836-41. PubMed ID: 10480616
    [Abstract] [Full Text] [Related]

  • 25. Effects of prolonged fasting and sustained lipolysis on insulin secretion and insulin sensitivity in normal subjects.
    Salgin B, Marcovecchio ML, Humphreys SM, Hill N, Chassin LJ, Lunn DJ, Hovorka R, Dunger DB.
    Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E454-61. PubMed ID: 19106250
    [Abstract] [Full Text] [Related]

  • 26. Lowering fatty acids potentiates acute insulin response in first degree relatives of people with type II diabetes.
    Paolisso G, Tagliamonte MR, Rizzo MR, Gualdiero P, Saccomanno F, Gambardella A, Giugliano D, D'Onofrio F, Howard BV.
    Diabetologia; 1998 Oct; 41(10):1127-32. PubMed ID: 9794097
    [Abstract] [Full Text] [Related]

  • 27. Dose-response effect of elevated plasma free fatty acid on insulin signaling.
    Belfort R, Mandarino L, Kashyap S, Wirfel K, Pratipanawatr T, Berria R, Defronzo RA, Cusi K.
    Diabetes; 2005 Jun; 54(6):1640-8. PubMed ID: 15919784
    [Abstract] [Full Text] [Related]

  • 28. Acute inhibition of lipolysis does not affect postprandial suppression of endogenous glucose production.
    Carey PE, Gerrard J, Cline GW, Dalla Man C, English PT, Firbank MJ, Cobelli C, Taylor R.
    Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E941-7. PubMed ID: 15998660
    [Abstract] [Full Text] [Related]

  • 29. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
    Henriksen JE, Levin K, Thye-Rønn P, Alford F, Hother-Nielsen O, Holst JJ, Beck-Nielsen H.
    Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980
    [Abstract] [Full Text] [Related]

  • 30. Acipimox-mediated plasma free fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli.
    Peino R, Cordido F, Peñalva A, Alvarez CV, Dieguez C, Casanueva FF.
    J Clin Endocrinol Metab; 1996 Mar; 81(3):909-13. PubMed ID: 8772549
    [Abstract] [Full Text] [Related]

  • 31. Metabolic Effects of Long-Term Reduction in Free Fatty Acids With Acipimox in Obesity: A Randomized Trial.
    Makimura H, Stanley TL, Suresh C, De Sousa-Coelho AL, Frontera WR, Syu S, Braun LR, Looby SE, Feldpausch MN, Torriani M, Lee H, Patti ME, Grinspoon SK.
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1123-33. PubMed ID: 26691888
    [Abstract] [Full Text] [Related]

  • 32. Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in noninsulin-dependent diabetes mellitus patients during a 3-day intensified treatment period.
    Worm D, Henriksen JE, Vaag A, Thye-Rønn P, Melander A, Beck-Nielsen H.
    J Clin Endocrinol Metab; 1994 Mar; 78(3):717-21. PubMed ID: 8126147
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of the rise in FFA by Acipimox partially prevents GH-induced insulin resistance in GH-deficient adults.
    Segerlantz M, Bramnert M, Manhem P, Laurila E, Groop LC.
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5813-8. PubMed ID: 11739444
    [Abstract] [Full Text] [Related]

  • 34. Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients.
    Miyazaki Y, Pipek R, Mandarino LJ, DeFronzo RA.
    Int J Obes Relat Metab Disord; 2003 Jan; 27(1):88-94. PubMed ID: 12532159
    [Abstract] [Full Text] [Related]

  • 35. Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression.
    Cordido F, Peino R, Peñalva A, Alvarez CV, Casanueva FF, Dieguez C.
    J Clin Endocrinol Metab; 1996 Mar; 81(3):914-8. PubMed ID: 8772550
    [Abstract] [Full Text] [Related]

  • 36. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism.
    Cordido F, Fernandez T, Martinez T, Peñalva A, Peinó R, Casanueva FF, Dieguez C.
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4350-4. PubMed ID: 9851776
    [Abstract] [Full Text] [Related]

  • 37. Reducing plasma free fatty acids by acipimox improves glucose tolerance in high-fat fed mice.
    Ahrén B.
    Acta Physiol Scand; 2001 Feb; 171(2):161-7. PubMed ID: 11350276
    [Abstract] [Full Text] [Related]

  • 38. Association of fasting plasma free fatty acid concentration and frequency of ventricular premature complexes in nonischemic non-insulin-dependent diabetic patients.
    Paolisso G, Gualdiero P, Manzella D, Rizzo MR, Tagliamonte MR, Gambardella A, Verza M, Gentile S, Varricchio M, D'Onofrio F.
    Am J Cardiol; 1997 Oct 01; 80(7):932-7. PubMed ID: 9382011
    [Abstract] [Full Text] [Related]

  • 39. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans.
    Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, Youngren JF, Havel PJ, Pratley RE, Bogardus C, Tataranni PA.
    Diabetes; 2002 Jun 01; 51(6):1884-8. PubMed ID: 12031977
    [Abstract] [Full Text] [Related]

  • 40. Effects of Acipimox on the metabolism of free fatty acids and very low lipoprotein triglyceride.
    Hannah JS, Bodkin NL, Paidi MS, Anh-Le N, Howard BV, Hansen BC.
    Acta Diabetol; 1995 Dec 01; 32(4):279-83. PubMed ID: 8750769
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.